• 제목/요약/키워드: Uterine Myoma

검색결과 84건 처리시간 0.205초

자궁근종 치료를 위한 질경유 초음파 유도하 고주파 자궁근종용해술의 장기간 효과에 대한 임상적 연구 (Clinical Study of Long Term Effect of Transvaginal Ultrasound Guided Radiofrequency Myolysis for Treatment of Uterine Leiomyoma)

  • 이우석;이일한;김동호;이상훈
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제35권1호
    • /
    • pp.77-82
    • /
    • 2008
  • 목 적: 질경유 초음파 유도하 고주파 자궁근종용해술의 임상적인 효과 및 안정성에 대해 분석해 보고자 하였다. 연구방법: 2004년 12월부터 2007년 3월사이에 질경유 초음파 유도하 고주파 자궁근종용해술을 시행받은 109명을 대상으로 하였다. 환자의 평균나이는 $42.8{\pm}5.8$세였고 모두 자궁을 보존하기 원하였다. 시술 전에 이학적 검사와 초음파를 이용한 병변의 크기 측정이 이루어졌다. 추적검사는 시술 후 1주일, 1개월, 3개월, 6개월 후 시행되었으며 동일 의사에 의해 크기 및 부피변화를 측정하였고, 방문 때마다 생리과다, 생리통 등의 근종 특이증상의 호전 유무를 추적 관찰하였다. 결 과: 근종의 평균 최대직경은 $6.1{\pm}0.5\;cm$ 이었고, 고주파용해술에 소요된 시간은 평균 $16.3{\pm}8.5$분이었다. 유의 할만한 크기와 부피의 감소는 시술 1개월 이후부터 발생하였으며 근종의 평균 최대직경은 시술 후 1주일, 1개월, 3개월, 6개월에 각각 $29.9{\pm}4.8%$ (p<0.001), $41.5{\pm}1.5%$ (p=0.05), $46.2{\pm}3.9%$ (p=0.003), $54.6{\pm}6.1%$ (p<0.001)의 감소율을 보였으며 평균 부피는 각각 $44.4{\pm}8.3%$ (p=0.001), $68.1{\pm}4.2%$ (p=0.035), $73.9{\pm}4.8%$ (p=0.042), $84.5{\pm}5.1%$ (p<0.001)의 부피 감소를 보였다. 일시적인 하복통과 출혈의 지속이 각각 3명씩 있었으나 모두 교정되었고 위중한 합병증은 발생되지 않았다. 생리통과 생리과다 등의 증상은 시술 3개월 후 유의하게 감소하였다. 결 론: 질경유 고주파 자궁근종용해술은 자궁을 보존하면서 좋은 효과와 조기 회복이 가능한 안전하고 효과적인 시술법이다.

자궁근종 환자에서 Gonadotropin Releasing Hormone(GnRH) 유사체 투여 후 자궁근종 세포 증식에 관한 연구 (The Activity of Proliferating Cell Nuclear Antigen(PCNA) of Uterine Myoma after Treatment with Gonadotropin Releasing Hormone(GnRH) Analogue)

  • 이병석;이보연;박기현;조동제;이국;송찬호;김호근
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제19권2호
    • /
    • pp.175-179
    • /
    • 1992
  • The factors involved in the initial neoplastic transformation and subsquent growth of uterine fibroid are poorly understood. The reduction in uterine fibroid volume associated with the chronic administration of the mechanisms mediating the decrease in fibroid volume in GnRH-a treated patients are poorly defined. The purpose of this study was to determine the proliferating cell nuclear antigen(PCNA) in fibroid from-women pretreated with GnRH analogue(GnRH-a) compared with controls. Tissue was obtained from 16 premenopausal women with uterine fibroid who received GnRH-a(D-Trp6-GnRH) intramusculary every 28 days for four injections. The mean proliferating index(PI) in patients with uterine fibroids was $2.25{\pm}0.9$, and in controls was $8.82{\pm}1.8$(P<0.001). The proliferating index was not corrleated with the reduction of fibroid volume. In this clinical study, although hypoestrogenism may be the main factor that reduce the volume of fibroid, other factors are also considered to be involved in that process. And the regrowth of uterine fibroid may be affected by increased production of PCNA after stopping GnRH-a.

  • PDF

트로카 삽입 부위에 생긴 림프관 확장을 동반한 기생 평활근종: 증례 보고 (Parasitic Leiomyoma with Lymphatic Dilatation in Trocar Port-Site of Abdominal Wall: A Case Report)

  • 전가영;박서영
    • 대한영상의학회지
    • /
    • 제84권1호
    • /
    • pp.280-285
    • /
    • 2023
  • 자궁 근종은 여성에서 가장 흔한 양성 골반 강 내 종양이며 증상이 있을 경우 수술적 제거를 하게 된다. 내시경 수술이 발달하게 되면서 포트 삽입 부위의 기생 평활 근종들이 보고되기 시작하였다. 40세의 여자 환자가 왼쪽 아랫배에서 만져지는 종괴를 주소로 외래로 내원하였고 2년 전 내시경 근종 제거를 받은 과거력이 있었다. 조영증강 CT와 MRI를 시행하여 해당 종괴에 대한 평가를 시행하였으며 수술적 제거를 시행하였다. 병리 검사에서 해당 종괴는 기생 평활 근종으로 최종 진단되었는데 이는 이전 내시경 근종 제거술을 시행한 환자에서 수술부위에 만져지는 종괴를 주소로 내원하였을 때 반드시 기생 평활 근종을 감별 진단으로 고려하여야 함을 시사한다.

자궁근종시 LHRH agonist (D-Trp6-LHRH) 치료에 따른 근종세포내 미세구조의 변화 (Electron Microscopic Ultrastructural Changes of Leiomyoma after Treatment with D-Trp6-Luteinizing Hormone Releasing Hormone)

  • 박기현;신명철;이보연;이병석;송찬호
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제18권2호
    • /
    • pp.189-196
    • /
    • 1991
  • Long-term administration of luteinizing hormone-releasing hormone(LHRH) agonists, through a process of pituitary desensitization and down-regulation of receptors, inhibits the secretion of gonadotropin and sex-steroids and induces a reversible suppression of gonadal activity. This approach can be used as an effective endocrine therapy for some hormone-dependent tumors. We have used D-Trp6-LHRH, a long acting LHRH agonist, for the treatment of eleven patients with uterine leiomyomas, thereafter myomectomy was performed in seven cases and observed the ultrastructural changes of leiomyoma with an electron microscope. The use of LHRH agonist may be effective in reducing the size of a myoma considerably by primarily inducing medical hypophysectomy and would allow easier surgical removal. Electron microscopic findings of myoma cells after the use of LHRH agonist included the following: loss of cristae and swelling nuclear chromatin, perinuclear vacuolation in cytoplasm. Bone mineral density was slightly decreased, however, the difference was not statistically significant.

  • PDF

자궁평활근종의 수술적 치료 후유증에 대한 보허탕가감방 한방 치험 5례 (Clinical Study of Korean Medicine with Boheo-tang-gagambang for Recovery after Gynecological Surgery for Myoma of the Uterus: 5 Cases Report)

  • 윤예슬;양승정;조성희
    • 대한한방부인과학회지
    • /
    • 제36권2호
    • /
    • pp.101-113
    • /
    • 2023
  • Objectives: The purpose of this case study is to report clinical effectiveness of the Boheo-tang-gagambang with acupuncture, moxa and physiotherapy treatments on the after-effects of myomectomy or hysterectomy. Methods: The subjects of this study were five women who were diagnosed with uterine myoma and underwent myomectomy or hysterectomy. They mainly complained of lower abdominal pain, back pain, and pelvic pain. They received combination treatment of Korean medicine and physiotherapy. The Korean medicine included Boheo-tang-gagambang, acupuncture and moxa. The effects were evaluated through Numeric Rating Scale (NRS). Results: In this study, patient's clinical symptoms, including lower abdominal pain, low back pain, and pelvic pain, improved after hospitalization treatment. Conclusions: This case report shows that the combination treatment of Korean medicine with Boheo-tang-gagambang, acupuncture and moxa may be effective for treating after-effects of myomectomy or hysterectomy.

Di-(2-ethylhexyl) Phthalate (DEHP) and Uterine Histological Characteristics

  • Cheon, Yong-Pil
    • 한국발생생물학회지:발생과생식
    • /
    • 제24권1호
    • /
    • pp.1-17
    • /
    • 2020
  • Phthalates and those metabolites have long history in industry and suspected to have deficient effects in development and reproduction. These are well-known anti-androgenic chemicals and many studies have examined the effects of these compounds on male reproduction as toxins and endocrine disruptors. Uterus is a key organ for proper embryo development, successful reproduction, and health of eutherian mammals including women. To understand the effects of the phthalate, the horizontal approach with a whole group of phthalate is best but the known phthalates are huge and all is not uncovered. Di-(2-ethylhexyl) phthalate (DEHP) is the most common product of plasticizers in polymer products and studied many groups. Although, there is limited studies on the effects of phthalates on the female, a few studies have proved the endocrine disrupting characters of DEHP or phthalate mixture in female. An acute and high dose of DEHP has adverse effects on uterine histological characters. Recently, it has been revealed that a chronical low-dose exposing of DEHP works as endocrine disrupting chemicals (EDC). DEHP can induce various cellular responses including the expression regulation of steroid hormone receptors, transcription factors, and paracrine factors. Interestingly, the response of uterus to DEHP is not monotonous and the exposed female has various phenotypes in fertility. These suggest that the exposing of DEHP may causes of histological modification in uterus and of disease in female such as endometriosis, hyperplasia, and myoma in addition to developmental and reproductive toxicity.

자궁선근증(子宮腺筋症)에 의한 불정자궁출혈(不定子宮出血)과 만성골반통(慢性骨盤痛)을 호소하는 환자 치험(治驗) 1례에 대한 보고 (A Case Report of One Patient with Adenomyosis)

  • 유성진;윤문희;김형준;이동녕
    • 대한한방부인과학회지
    • /
    • 제22권4호
    • /
    • pp.205-214
    • /
    • 2009
  • Purpose: Adenomyosis is the disease caused by ingrowth of lining tissue into the uterine muscle. Final treatment of the disease is hysterectomy but there is a tendency to avoid surgical treatment if possible. And medication often results in relapse and it does not cure completely. This paper introduces the potential of oriental medical treatment for adenomyosis through a case study. Methods: A 31-year-old female patient, suffered from pelvic pain and metrorrhagia, was diagnosed with adenomyosis and uterine myoma. She was put on oriental medical treatment in the ○○ Oriental Hospital for almost three months. We applied herb-medication, acupuncture and moxibustion. Results: Overall condition including the symptoms was relieved after oriental medical treatment Conclusion: Oriental medical treatment alleviates chronic pelvic pain and has an effect against adenomyosis.

다발성으로 폐에 발생한 양성 전이성 평활근종 (Multiple Pulmonary Benign Metastasizing Leiomyoma)

  • 전준경;이교선;송상윤;안병희;나국주
    • Journal of Chest Surgery
    • /
    • 제40권11호
    • /
    • pp.789-792
    • /
    • 2007
  • 양성 전이성 평활근종은 조직학적으로는 양성이나 임상적으로 폐나 다른 장기로 원격전이를 하는 매우 드문 질환이다. 저자들은 10년 전 자궁평활근종 절제술을 시행한 환자의 폐에서 발견된 다발성 결절 일부를 흉강경 수술하에 절제하여 조직학적 및 면역염색검사로 양성 전이성 평활근종임을 진단할 수 있었다. 환자는 수술 후 종양의 크기 변화 및 특이 증상이 없으며 특별한 치료 없이 외래 추적관찰 중이다.

자궁근종과 생식력 (Fertility Issues in Patients with Myoma)

  • 김소라;채희동
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제37권3호
    • /
    • pp.191-198
    • /
    • 2010
  • 자궁근종은 환자마다 다양한 조성, 크기, 위치, 개수를 가지는 양성 종양으로 여러 가지 방법으로 생식력에 영향을 준다. 자궁근종이 생식률에 미치는 영향에 대한 연구는 많이 시행되어 왔지만 여전히 명확한 결론을 내리기는 어렵다. 자궁근종의 위치와 크기는 향후 임신에 영향을 미치는 가장 중요한 인자이다. 장막하근종은 임신에 거의 영향을 주지 않으나 자궁내강의 모양을 변형시키는 점막하근종과 근층내근종은 임신율을 감소시키며 자연 유산율을 증가시킨다. 그러므로 보조생식술을 시행하기 전에는 먼저 제거하는 치료가 충분히 상의되어야 한다. 자궁내강을 변형시키지 않은 근층내근종이 있는 환자도 임신율의 저하를 보였지만, 확실한 연구가 없기 때문에 결론을 내리기가 쉽지 않다. 근층내근종의 치료로 근종절제술이 생식력을 향상시킨다는 증거는 아직 불충분하므로 환자의 상태와 의사의 경험에 따라 치료 방법을 결정하여야 한다.

불임증(不姙症) 환자(患者)의 통계적(統計的) 고찰(考察);서울대학교병원(大學校病院) 불임상담실(不姙相談室) 1872 예(例)의 분석(分析) (An Analysis of Infertility Patients)

  • 장윤석;이진용;문신용;김정구;최승헌;임용택
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제12권1호
    • /
    • pp.47-70
    • /
    • 1985
  • This study was presented of the 1,872 cases of infertile couples who visited and examined at the sterility clinic of Department of Obstetrics & Gynecology, Seoul National University Hospital from Sept., 1980 to Dec., 1983. Age, duration of infertility, past medical history, and other general factors were analyzed, and the factors responsible for infertility were classified and discussed. Mode of treatment, outcome of pregnancy, pregnancy rate responsible for each factor were also presented. The results were as follows: 1) The infertility was primary in 1,128, or 60.3% and secondary in 744, or 39.7%. 2) The age between 26 and 30 years of age comprised about one half of the total patients. 3) The duration of infertility between 1 and 4 years comprised about three quarters of the total patients, and the mean duration was 3.8 years. 4) The most common medical history in primary infertility was tuberculous disease, and that in secondary infertility was history of previous laparotomy. 5) About two thirds of antecedent pregnancies were abortion. 6) The major etiologic factor of infertility were male factor in 12.3%, tubal factor in 38.8%, ovulatory failure in 25.4%, uterine factor in 8.8%, cervical factor in 5.2%, peritoneal factor in 9.5%, and no demonstrable cause in 11.3%. 7) The types of male factor were azoospermia in 61.6%, oligospermia in 25.8%, low motility in 11.6%, and other abnormality in 1.0%. 8) The types of ovulatory failure were ovarian failure in 7.4%, hypothalamo-pituitary failure in 8.1 %, hypothalamo-pituitary dysfunction (including Polycystic ovarian syndrome) in 30.2%, and hyperprolactinemia in 22.4%. 9) The types of uterine factor were endometrial tuberculosis in 27.5%, uterine synechia in 33.8%, uterine anomaly in 19.7%, myoma and polyp in 9.1 %, and luteal phase defect in 9.9%. 10) The types of peritoneal factor were pelvic adhesion in 80.9% and endometriosis in 19.6%. 11) Surgeries were done in 408 patients, and they were salpingolysis, lysis of extraadnexal adhesion, salpingostomy, fimbrioplasty, ovarian wedge resection for polycystic ovarian disease, tubo-tubal anastomosis, and tubo-uterine implantation in orders. 12) 243 pregnancies were achieved during the infertility work-up, of which livebirth was 46.5%, ectopic pregnancy was 7.4%, spontaneous abortion was 7.8%, and on-going pregnancy or lost to follow-up was 36.2%. 13) Pregnancy rates in various factors were male factor in 18.7%, ovulatory factor in 31.7%, tubal factor in 24.2%, uterine factor in 34.6%, cervical factor in 19.0%, peritoneal factor in 29.0%, combined factors in 10.5%, and unexplained infertility in 37.1%. Pregnancy rate in whole patients was 25.2%.

  • PDF